Mohammed Al Kanan: Early Identification of VTE Risk in Lung Cancer Patients
Mohammed Al Kanan, Director of Research and Studies at Ministry of Health Saudi Arabia, shared a post on LinkedIn about a recent article by Rong Deng et al. published in Frontiers in Molecular Biosciences, adding:
“Pleased to have contributed as a peer reviewer for a newly published original research article in Frontiers in Molecular Biosciences:
Construction and verification of a nomogram to predict the probability of venous thromboembolism in lung cancer patients.
This study tackles an important challenge in oncology: early identification of lung cancer patients at increased risk of venous thromboembolism (VTE) to support more individualized thromboprophylaxis and clinical decision-making.
Among 676 patients with lung cancer, the investigators developed a lung cancer–specific predictive nomogram incorporating clinically relevant factors such as acute infection, prolonged bed rest, D-dimer, adenocarcinoma, CEA, and COMPASS-CAT score.
What makes the findings particularly interesting is the model’s performance: AUC 0.894, outperforming several conventional VTE risk assessment tools, with favorable discrimination and calibration.
The work represents another step toward moving from generalized risk scores to more disease-specific and individualized prediction models—while prospective validation remains essential before widespread clinical implementation.
Grateful for the opportunity to contribute to the peer-review process and advancement of clinically relevant research.”
Title: Construction and verification of a nomogram to predict the probability of venous thromboembolism in lung cancer patients
Authors: Rong Deng, Jing Wu, Fei Tang, Yan Li, Qin Zhong, Ying Tong, Tingting Ni, Yu Zhang
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 6, 2026, 18:17Aryabhatta Sadhu: Irradiation of Blood Components – From Clinical Indication to Laboratory Release
-
Sep 6, 2026, 18:15Ashenafi Tazebew Amare: A Year of Progress, Transformation and Renewed Commitment
-
Sep 6, 2026, 18:13Emilio Osorio: Can Anticoagulation Be Safely Discontinued After Surgical Left Atrial Appendage Occlusion?
-
Sep 6, 2026, 18:11Razan Alolyani: Our Research on Anticoagulation After Acute Ischemic Stroke Receives 2nd Place
-
Sep 6, 2026, 18:10Chayakrit Krittanawong: Have You Heard of Blood Clots in the Legs?
-
Sep 6, 2026, 18:08Trilok Chand: Microplastics Found in Human Testes and Blood Clots
-
Sep 6, 2026, 18:07Sarah Moharem Elgamal: Cardiovascular Imaging Beyond Anatomy Toward Earlier Risk Prediction
-
Sep 6, 2026, 16:41Christina P.: APS – How it Happens in Your Blood, the Warning Signs, and What to Do about It
-
Sep 6, 2026, 16:33Jose Angel Nicolas Avila: How Tissue Mitochondrial Activity Dictates Macrophage Pool Size